BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 21194532)

  • 1. Flow cytometry-based assay to evaluate human serum MUC1-Tn antibodies.
    Van Elssen CH; Clausen H; Germeraad WT; Bennet EP; Menheere PP; Bos GM; Vanderlocht J
    J Immunol Methods; 2011 Feb; 365(1-2):87-94. PubMed ID: 21194532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant MUC1 mucin with a breast cancer-like O-glycosylation produced in large amounts in Chinese-hamster ovary cells.
    Bäckström M; Link T; Olson FJ; Karlsson H; Graham R; Picco G; Burchell J; Taylor-Papadimitriou J; Noll T; Hansson GC
    Biochem J; 2003 Dec; 376(Pt 3):677-86. PubMed ID: 12950230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel cancer-specific immunodominant glycopeptide epitope in the MUC1 tandem repeat.
    Tarp MA; Sørensen AL; Mandel U; Paulsen H; Burchell J; Taylor-Papadimitriou J; Clausen H
    Glycobiology; 2007 Feb; 17(2):197-209. PubMed ID: 17050588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmembrane and secreted MUC1 probes show trafficking-dependent changes in O-glycan core profiles.
    Engelmann K; Kinlough CL; Müller S; Razawi H; Baldus SE; Hughey RP; Hanisch FG
    Glycobiology; 2005 Nov; 15(11):1111-24. PubMed ID: 15972891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human tumor antigen MUC1 expressed in insect cells: structure and immunogenicity.
    Soares M; Hanisch FG; Finn OJ; Ciborowski P
    Protein Expr Purif; 2001 Jun; 22(1):92-100. PubMed ID: 11388805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human single-chain Fv antibodies to MUC1 core peptide selected from phage display libraries recognize unique epitopes and predominantly bind adenocarcinoma.
    Henderikx P; Kandilogiannaki M; Petrarca C; von Mensdorff-Pouilly S; Hilgers JH; Krambovitis E; Arends JW; Hoogenboom HR
    Cancer Res; 1998 Oct; 58(19):4324-32. PubMed ID: 9766660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoenzymatically synthesized multimeric Tn/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override tolerance.
    Sørensen AL; Reis CA; Tarp MA; Mandel U; Ramachandran K; Sankaranarayanan V; Schwientek T; Graham R; Taylor-Papadimitriou J; Hollingsworth MA; Burchell J; Clausen H
    Glycobiology; 2006 Feb; 16(2):96-107. PubMed ID: 16207894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MUC1-derived glycopeptide libraries with improved MHC anchors are strong antigens and prime mouse T cells for proliferative responses to lysates of human breast cancer tissue.
    Gad M; Jensen T; Gagne R; Komba S; Daugaard S; Kroman N; Meldal M; Werdelin O
    Eur J Immunol; 2003 Jun; 33(6):1624-32. PubMed ID: 12778480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioprocess development for the production of a recombinant MUC1 fusion protein expressed by CHO-K1 cells in protein-free medium.
    Link T; Bäckström M; Graham R; Essers R; Zörner K; Gätgens J; Burchell J; Taylor-Papadimitriou J; Hansson GC; Noll T
    J Biotechnol; 2004 May; 110(1):51-62. PubMed ID: 15099905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant epithelial cell mucin (MUC-1) expressed in baculovirus resembles antigenically tumor associated mucin, target for cancer immunotherapy.
    Ciborowski P; Finn OJ
    Biomed Pept Proteins Nucleic Acids; 1995; 1(3):193-8. PubMed ID: 9346852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased immunogenicity of tumor-associated antigen, mucin 1, engineered to express alpha-gal epitopes: a novel approach to immunotherapy in pancreatic cancer.
    Deguchi T; Tanemura M; Miyoshi E; Nagano H; Machida T; Ohmura Y; Kobayashi S; Marubashi S; Eguchi H; Takeda Y; Ito T; Mori M; Doki Y; Sawa Y
    Cancer Res; 2010 Jul; 70(13):5259-69. PubMed ID: 20530670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-dependent cell-mediated cytotoxicity can be induced by MUC1 peptide vaccination of breast cancer patients.
    Snijdewint FG; von Mensdorff-Pouilly S; Karuntu-Wanamarta AH; Verstraeten AA; Livingston PO; Hilgers J; Kenemans P
    Int J Cancer; 2001 Jul; 93(1):97-106. PubMed ID: 11391628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of O-glycans in MUC1 glycoproteins using electron-capture dissociation fragmentation mass spectrometry.
    Sihlbom C; van Dijk Härd I; Lidell ME; Noll T; Hansson GC; Bäckström M
    Glycobiology; 2009 Apr; 19(4):375-81. PubMed ID: 19095697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear magnetic resonance-based dissection of a glycosyltransferase specificity for the mucin MUC1 tandem repeat.
    Brokx RD; Revers L; Zhang Q; Yang S; Mal TK; Ikura M; Gariépy J
    Biochemistry; 2003 Dec; 42(47):13817-25. PubMed ID: 14636048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of N- and O-glycosylation inhibitors on the glycosylation profile of cellular membrane proteins and adhesive properties of carcinoma cell lines.
    Paszkiewicz-Gadek A; Porowska H; Lemancewicz D; Wolczynski S; Gindzienski A
    Int J Mol Med; 2006 Apr; 17(4):669-74. PubMed ID: 16525726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular evolution of specific human antibody against MUC1 mucin results in improved recognition of the antigen on tumor cells.
    Persson J; Bäckström M; Johansson H; Jirström K; Hansson GC; Ohlin M
    Tumour Biol; 2009; 30(4):221-31. PubMed ID: 19776674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MUC1/X protein immunization enhances cDNA immunization in generating anti-MUC1 alpha/beta junction antibodies that target malignant cells.
    Rubinstein DB; Karmely M; Ziv R; Benhar I; Leitner O; Baron S; Katz BZ; Wreschner DH
    Cancer Res; 2006 Dec; 66(23):11247-53. PubMed ID: 17145869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and preclinical evaluation of a Bacillus Calmette-Guérin-MUC1-based novel breast cancer vaccine.
    Chung MA; Luo Y; O'Donnell M; Rodriguez C; Heber W; Sharma S; Chang HR
    Cancer Res; 2003 Mar; 63(6):1280-7. PubMed ID: 12649188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure/activity studies of the anti-MUC1 monoclonal antibody C595 and synthetic MUC1 mucin-core-related peptides and glycopeptides.
    Spencer DI; Missailidis S; Denton G; Murray A; Brady K; Matteis CI; Searle MS; Tendler SJ; Price MR
    Biospectroscopy; 1999; 5(2):79-91. PubMed ID: 10217327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of a MUC1-based cancer vaccine.
    Hanisch FG
    Biochem Soc Trans; 2005 Aug; 33(Pt 4):705-8. PubMed ID: 16042579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.